Cargando…

Novel tri-specific tribodies induce strong T cell activation and anti-tumor effects in vitro and in vivo

BACKGROUND: Immunotherapy based on Bi-specific T Cell Engagers (TCE) represents one of the most attractive strategy to treat cancers resistant to conventional therapies. TCE are antibody-like proteins that simultaneously bind with one arm to a Tumor Associated Antigen (TAA) on cancer cells and with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Passariello, Margherita, Yoshioka, Asami, Takahashi, Kota, Hashimoto, Shu-ichi, Inoue, Toshikazu, Nakamura, Koji, De Lorenzo, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450414/ https://www.ncbi.nlm.nih.gov/pubmed/36071464 http://dx.doi.org/10.1186/s13046-022-02474-3

Ejemplares similares

Novel Bi-Specific Immuno-Modulatory Tribodies Potentiate T Cell Activation and Increase Anti-Tumor Efficacy
por: Passariello, Margherita, et al.
Publicado: (2022)

A Comparison of the Antitumor Efficacy of Novel Multi-Specific Tribodies with Combinations of Approved Immunomodulatory Antibodies
por: Manna, Lorenzo, et al.
Publicado: (2023)

Tribody [(HER2)(2)xCD16] Is More Effective Than Trastuzumab in Enhancing γδ T Cell and Natural Killer Cell Cytotoxicity Against HER2-Expressing Cancer Cells
por: Oberg, Hans H., et al.
Publicado: (2018)

Interactions of Spike-RBD of SARS-CoV-2 and Platelet Factor 4: New Insights in the Etiopathogenesis of Thrombosis
por: Passariello, Margherita, et al.
Publicado: (2021)

Strong Antibiotic Activity of the Myxocoumarin Scaffold in vitro and in vivo
por: Hertrampf, Gesa, et al.
Publicado: (2022)

Novel Human Bispecific Aptamer–Antibody Conjugates for Efficient Cancer Cell Killing
por: Passariello, Margherita, et al.
Publicado: (2019)

Genotoxicity of Tri- and Hexavalent Chromium Compounds In Vivo and Their Modes of Action on DNA Damage In Vitro
por: Fang, Zhijia, et al.
Publicado: (2014)

New Insights on the Role of Anti-PD-L1 and Anti-CTLA-4 mAbs on Different Lymphocytes Subpopulations in TNBC
por: Lembo, Rosa Rapuano, et al.
Publicado: (2022)

Ipilimumab and Its Derived EGFR Aptamer-Based Conjugate Induce Efficient NK Cell Activation against Cancer Cells
por: Passariello, Margherita, et al.
Publicado: (2020)

Detection of foaling using a tail-attached device with a thermistor and tri-axial accelerometer in pregnant mares
por: Aoki, Takahiro, et al.
Publicado: (2023)

Immunomodulatory mAbs as Tools to Investigate on Cis-Interaction of PD-1/PD-L1 on Tumor Cells and to Set Up Methods for Early Screening of Safe and Potent Combinatorial Treatments
por: Vetrei, Cinzia, et al.
Publicado: (2021)

Certifying achievement in the control of Chagas disease native vectors: what is a viable scenario?
por: Hashimoto, Ken, et al.
Publicado: (2014)

Expression of c‐met/HGF Receptor in Human Non‐small Cell Lung Carcinomas in vitro and in vivo and Its Prognostic Significance
por: Ichimura, Eiji, et al.
Publicado: (1996)

Titanium Salan Complexes Displays Strong Antitumor Properties In Vitro and In Vivo in Mice
por: Immel, Timo A., et al.
Publicado: (2011)

Comparative Analysis of a Human Neutralizing mAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays
por: Passariello, Margherita, et al.
Publicado: (2023)

Novel Combinations of Human Immunomodulatory mAbs Lacking Cardiotoxic Effects for Therapy of TNBC
por: Vetrei, Cinzia, et al.
Publicado: (2021)

Trying to Understand NK Cell Function in vivo Points towards a Severity Score for CVID Patients
por: Wehr, Claudia
Publicado: (2016)

The chitosan/tri-calcium phosphate bio-composite bone cement promotes better osteo-integration: an in vitro and in vivo study
por: Fang, Chih-Hsiang, et al.
Publicado: (2019)

Has the prevalence of Chagas disease increased in Central Latin America?
por: Yoshioka, Kota, et al.
Publicado: (2020)

A long non-coding SINEUP RNA boosts semi-stable production of fully human monoclonal antibodies in HEK293E cells
por: Sasso, Emanuele, et al.
Publicado: (2018)

High-Throughput Monoclonal Antibody Discovery from Phage Libraries: Challenging the Current Preclinical Pipeline to Keep the Pace with the Increasing mAb Demand
por: Zambrano, Nicola, et al.
Publicado: (2022)

Novel Human Anti-PD-L1 mAbs Inhibit Immune-Independent Tumor Cell Growth and PD-L1 Associated Intracellular Signalling
por: Passariello, Margherita, et al.
Publicado: (2019)

Tri11, tri3, and tri4 genes are required for trichodermin biosynthesis of Trichoderma brevicompactum
por: Shentu, Xuping, et al.
Publicado: (2018)

A Novel Human Neutralizing mAb Recognizes Delta, Gamma and Omicron Variants of SARS-CoV-2 and Can Be Used in Combination with Sotrovimab
por: Passariello, Margherita, et al.
Publicado: (2022)

Cobalt–Chromium Alloy Has Superior Antibacterial Effect Than Titanium Alloy: In Vitro and In Vivo Studies
por: Watanabe, Kota, et al.
Publicado: (2021)

Tri-layered composite plug for the repair of osteochondral defects: in vivo study in sheep
por: Yucekul, Altug, et al.
Publicado: (2017)

Identification of the Control Region of Pancreatic Expression of Bmp4 In Vitro and In Vivo
por: Yasunaga, Mayu, et al.
Publicado: (2013)

TriQuarterly.
Publicado: (1964)

Trying times
por: Jankharia, Bhavin
Publicado: (2009)

TriDAS
por: Smith, W
Publicado: (1999)

TriQuinoline
por: Adachi, Shinya, et al.
Publicado: (2019)

Trying Times
por: Rodriguez, L. Leonardo, et al.
Publicado: (2020)

Jones Tries It on
Publicado: (1905)

Tri-antennary tri-sialylated mono-fucosylated glycan of alpha-1 antitrypsin as a non-invasive biomarker for non-alcoholic steatohepatitis: a novel glycobiomarker for non-alcoholic steatohepatitis
por: Ogawa, Koji, et al.
Publicado: (2020)

Tri(boryl)alkanes and Tri(boryl)alkenes: The Versatile Reagents
por: Salvadó, Oriol, et al.
Publicado: (2020)

If at first you don't succeed, try, try, try again. A message for Public Health Research in Belgium
por: Van Oyen, H
Publicado: (2009)

Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo
por: Oyama, Tomomi, et al.
Publicado: (2007)

Evidences of CTLA-4 and PD-1 Blocking Agents-Induced Cardiotoxicity in Cellular and Preclinical Models
por: Quagliariello, Vincenzo, et al.
Publicado: (2020)

Variation of 4 MV X-ray dose rate strongly impacts biological response both in vitro and in vivo
por: Ben Kacem, M., et al.
Publicado: (2020)

In vivo and in vitro mutagenicity of perillaldehyde and cinnamaldehyde
por: Honma, Masamitsu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pvjgug5319gtgsi8jd738g1260